Showing 34,667 results

Injectable & long-acting PrEP

Gilead Sciences Announces New Clinical Trial in Europe to Assess Lenacapavir for HIV Prevention as Part of Landmark Purpose Program

Editor's pick
Gilead Sciences press release
19 October 2023
Bad science & bogus treatments

Beware of this dangerous advice! Colloidal silver cannot be used as an antibiotic or HIV medication

Editor's pick
Africa Check
19 October 2023
People with limited treatment options

Sunlenca Remains Active Against Drug-Resistant HIV

Editor's pick
POZ
19 October 2023
Exposure to HIV through medical procedures

‘I stopped counting how many friends died’: life after the contaminated blood scandal

Editor's pick
The Guardian
19 October 2023
HIV treatment

Real-World Evidence Reinforces Biktarvy® as a Long-Term Treatment Option With a High Barrier to Resistance for People With HIV and a Range of Comorbidities

Editor's pick
Gilead Sciences press release
19 October 2023
Migrants, refugees & displaced people

More than six out of ten migrant gay and bisexual men with HIV in France acquired it there

News
19 October 2023
News about aidsmap

Picture this – living with HIV

News
18 October 2023
Neurological & cognitive problems

HIV in the brain – does it correlate with neurocognitive symptoms?

News
18 October 2023

DoxyPEP: antibiotics to prevent STIs – HIV update, 17 October 2023

October 2023
People with limited treatment options

Intramuscular Administration of HIV Treatment Ibalizumab Compared With IV Infusion

Editor's pick
Monthly Prescribing Reference
17 October 2023
Hepatitis B

Hepatitis B Reactivation Risk Low in People With HIV Following Antiretroviral Switch

Editor's pick
Contagion Live
17 October 2023
Combatting stigma

Young HIV advocates stand up to fake news and stigma

Editor's pick
UNICEF
17 October 2023
Cancer

Only Half of MSM With HIV Getting Screened for Anal Cancer

Editor's pick
NATAP
17 October 2023
Quality of life

Each Added Comorbidity Cuts 4 Points Off QOL Index in US Women With HIV

Editor's pick
NATAP
17 October 2023
Injectable & long-acting HIV treatment

Over 80% With Detectable HIV Load Respond to CAB + RPV LA

Editor's pick
NATAP
17 October 2023
Neurological & cognitive problems

What HIV does to your brain — and how ARVs halt that

Editor's pick
Bhekisisa
17 October 2023
Injectable & long-acting HIV treatment

Treatment Adherence, Persistence in HIV Improves After Switch to Long-Acting ART

Editor's pick
Infectious Disease Advisor
17 October 2023
People with limited treatment options

Long-Term Outcomes of Fostemsavir in HTE Adults With Advanced HIV

Editor's pick
Infectious Disease Advisor
17 October 2023
Conference announcements & declarations

International AIDS Society Strikes “HIV-Infected” From Its Lexicon

Editor's pick
TheBody
17 October 2023
Mpox (monkeypox)

Studies: Undetected mpox unlikely, household spread limited

Editor's pick
CIDRAP
17 October 2023
PEP

PEP-in-Pocket Is Another Option for HIV Prevention

Editor's pick
POZ
17 October 2023
Injectable & long-acting PrEP

PrEPster at The Love Tank joins community call for injectable PrEP

Editor's pick
Prepster
17 October 2023
PEP

Making PEP available in the community could reduce new HIV cases in Africa by 31%

News
17 October 2023

Незабаром: новини з EACS 2023

October 2023